Treatment of Peri-Implant Mucositis
Study Overview
This study compared the effectiveness of two treatments for peri-implant mucositis: an Er:YAG laser and an ultrasonic device. The goal was to see how these treatments affected pain, appearance, and overall quality of life over six months.
Methods
Each patient received one dental implant treatment. They were randomly assigned to receive either the Er:YAG laser (test group) or the ultrasonic scaler (control group). Treatments occurred at the start, three months, and six months later. Patients were also taught proper oral hygiene techniques after each session.
Results
Forty-six patients participated in the study. Key findings include:
- Full Mouth Bleeding on Probing (FMBoP): Decreased significantly in both groups, with the laser group going from 30.1% to 21.5% and the control group from 35.0% to 30%.
- Full Mouth Plaque Score (FMPS): Also showed significant improvement, with the laser group reducing from 61.5% to 32.7% and the control group from 58.7% to 39.1%.
- Implant Bleeding on Probing (BoP): Decreased from 89.0% to 55.7% in the laser group and from 94.9% to 63.7% in the control group.
- Pain Levels: Reported pain was lower in the laser group at three days post-treatment.
Conclusions
Both treatment methods were effective for peri-implant mucositis, but the laser treatment resulted in fewer diseased sites after six months.
Clinical Trial Registration
Registered at clinicaltrials.gov: study no, NCT05772299.
Value of Clinical Trials
Clinical trials play a crucial role in developing safe and effective treatments. It’s essential to integrate these findings into everyday medical practice.
Practical Solutions
DocSym, our AI-driven platform, offers:
- Consolidated Knowledge Base: Access to ICD-11 standards, clinical protocols, and research.
- Mobile Apps: Tools for scheduling, monitoring treatments, and telemedicine to enhance patient care.
- Improved Workflow: AI helps clinics streamline operations and reduce paperwork.
Learn more about how we can assist at aidevmd.com.